Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

288
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
288
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical risk factors and prediction model for gonadal impairment in pediatric patients following hematopoietic stem cell transplantation.

Scientific reports·2026
Same author

Impact of voriconazole/posaconazole on CsA in paediatric allogeneic haematopoietic stem cell transplantation recipients: A real-world study.

British journal of clinical pharmacology·2026
Same author

Associations of bowel movements and stool types with risk of chronic kidney disease.

Medicine·2026
Same author

[Semaphorin 3B membranous nephropathy after hematopoietic stem cell transplantation in a child: a case report and literature review].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026
Same author

High proportion of peripheral blood and haploidentical stem cell transplantation in Chinese children: a nationwide CCBMTR analysis.

Bone marrow transplantation·2026
Same author

Accelerated response and reduced chemotherapy with ruxolitinib-based regimen therapy in pediatric hemophagocytic lymphohistiocytosis: a retrospective comparison with HLH-94 regimen.

Frontiers in immunology·2026
Same journal

Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity.

Frontiers in immunology·2026
Same journal

Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants.

Frontiers in immunology·2026
Same journal

Enhancing immunotherapy efficacy in multiple myeloma and chronic lymphocytic leukemia: from combinatorial therapeutic approaches to gut microbiota modulation.

Frontiers in immunology·2026
Same journal

Editorial: Immune-related biomarkers in skin and breast cancer: innovations in immunological diagnostics and therapies.

Frontiers in immunology·2026
Same journal

Case report: Recurrence of anti-myeloperoxidase pauci-immune crescentic glomerulonephritis in a kidney transplant recipient; potential association with HLA antigens and seropositivity?

Frontiers in immunology·2026
Same journal

Case Report: Benralizumab combined with a steroid-sparing strategy in a case of severe eosinophilic granulomatosis with polyangiitis.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Jan 16, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

530

Age-enhanced MAGIC algorithm predicts mortality in pediatric aGVHD: a multicenter study.

Na Song1, Hao Xiong2, Ri Xu3

  • 1Department of Hematology/Oncology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), Changsha, China.

Frontiers in Immunology
|September 29, 2025
PubMed
Summary
This summary is machine-generated.

The Panel 2 score, combined with age, effectively predicts non-relapse mortality and overall survival in pediatric patients with acute graft-versus-host disease (aGVHD) after stem cell transplantation.

Keywords:
MAGIC algorithmacute graft-versus-host diseaseallogeneic hematopoietic stem cell transplantationnon-relapse mortalitypediatricrisk stratification

More Related Videos

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
09:24

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

Published on: May 17, 2024

2.1K
Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.1K

Related Experiment Videos

Last Updated: Jan 16, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

530
Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
09:24

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

Published on: May 17, 2024

2.1K
Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.1K

Area of Science:

  • Pediatric Hematology
  • Transplantation Immunology
  • Oncology

Background:

  • Acute graft-versus-host disease (aGVHD) significantly increases non-relapse mortality (NRM) in pediatric allogeneic hematopoietic stem cell transplantation (allo-HSCT).
  • The MAGIC algorithm's predictive capacity for aGVHD in children is not well-established.

Purpose of the Study:

  • To evaluate the predictive value of the Panel 2 score, in conjunction with age, for outcomes in pediatric patients with aGVHD undergoing allo-HSCT.
  • To assess the efficacy of the Panel 2 score in stratifying risk and predicting treatment response.

Main Methods:

  • A prospective multicenter cohort study of 105 Chinese pediatric allo-HSCT recipients with aGVHD.
  • Analysis included 6-month NRM, overall survival (OS), and Day-28 treatment response.
  • Multivariable analyses used Cox and logistic regression, incorporating clinical variables and the Panel 2 score.

Main Results:

  • Age ≥12 years and a high Panel 2 score were independent predictors of 6-month NRM and OS.
  • A high-risk group (age ≥12 and high Panel 2 score) showed significantly higher NRM (71% vs 12.2%) and worse OS compared to the low-risk group.
  • Panel 2 also predicted Day-28 treatment response, with lower complete/partial response rates in the high-risk group.

Conclusions:

  • The Panel 2 score is a valuable predictor of NRM, OS, and treatment response in pediatric aGVHD.
  • Combining Panel 2 score with age ≥12 years improves risk stratification, clearly separating high- and low-risk groups.
  • Further validation in larger international cohorts is warranted to support clinical utility.